Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Study of Intravenous Administration of MiSaver (Umbilical Cord Blood Derived Nucleated Cells) After Acute Myocardial Infarction

NCT07134712 is registered in ClinicalTrials.gov with HONYA Medical Co Ltd as lead sponsor.

NCT NCT07134712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07134712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Study of Intravenous Administration of MiSaver (Umbilical Cord Blood Derived Nucleated Cells) After Acute Myocardial Infarction
Lead sponsor
HONYA Medical Co Ltd
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 30, 2026
Completion date
December 31, 2027
Enrollment
102 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction (ami)